1[1]Schwarzberg-MN. Application of metoclopramide specificity in migraine attacks therapy[J]. Headache 1994,34（7）:439－41.
2[2]Ellis-GL; Delaney-J; DeHart-DA. The efficacy of metoclopramide in the treatmenr of migraine headache[J]. Ann-Emerg-Med. 1993,22(2)191-5.
3[3]Del-Zompo-M; Lai-M; Loi-V. Dopamine hypersensitivity in migraine:role in apomorphine syncope[J].Headache. 1995,35(4):222-4.
4[4]Kuritzky-A; Bennet-E; Hering-R. Reduced sensitivity of lymphocyte beta-adrenergic re-ceptors in migraine[J]. Headache 1993,33（4）:198－200.
5[5]Gallai-v; Flridi-A; Mazzotta-G; L-argininel nitric oxide pathway activation in plate lets of migraine patients with and without aura[J]. Acta-Neurol-Scand. 1996,94(2):151-60.
6[6]Gallai-V; Sarchielli-P; Morucci-P. Magnesium content of mononuclear blood cells in migraine patients see comments[J]. Headache 1994,34(3):160-5.
7李义召.山东省神经内科学学术年会论文汇编[J].山东菏泽,1997,(283).
8[8]Young; Gauai-V; Sarchielli-p. Serum and salivary magnesium levels in migraine. Resum and salivary magnesium levels in migraine. Results in a group of juvenule patients[J]. Headche. 1992,32(3):132-5.
